Preliminary Presentations

 

Click here to download Preliminary List of Scientific Presentations as a pdf.


PRELIMINARY LIST OF SCIENTIFIC PRESENTATIONS

Arranged in alphabetical order as of March 20, 2017

OCT-guided vs IVUS-guided PCI
Takashi Akasaka, Wakayama Medical University, Japan

Atrial Fibrillation and Geriatric Syndromes
Kannayiram Alagiakrishnan, University of Alberta, Edmonton, Alberta, Canada

The Role of Isolated Ultrafiltration in the Management of Chronic Refractory and Acute Decompensated Heart Failure
Martin A. Alpert, University of Missouri Health Sciences Center, Columbia, MO, USA

Vasculoprotective effects of Natriuretic Peptide Receptor-C
Madhu B. Anand-Srivastava, Faculty of Medicine, University of Montreal, Montréal, Québec, Canada

A Brief History of the Development of Mechanical Circulatory Support
Francisco A. Arabía, Cedars-Sinai Medical Center. Heart Institute, Los Angeles, CA, USA

Combination therapy of lipid disorders. Can we really reduce the residual risk effectively?
Maciej Banach, MUL, Lodz, Poland

Revascularization in Patients with Diabetes Mellitus: Optimal Approach in 2017
Gregory Barsness, Mayo Clinic, Rochester, MN, USA

Will Guidelines Still Pertain in the Era of PCSK9i?
Seth J. Baum, Boca Raton Regional Hospital, FL, USA

Cardio-Oncology: Cardiotoxicity and Heart Failure After Chemotherapy
Jutta Bergler-Klein, Medical University of Vienna, Vienna, Austria

Beyond stenosis: Ischemia and Plaque assessments by Coronary CTA
Daniel S. Berman, Cedars Sinai Medical Center, Los Angeles, CA, USA

Epigenetic Signature of ACS
Luigi Marzio Biasucci, Catholic University of the Sacred Heartת , Rome, Italy

Pacemakers and Defibrillators in the MRI Environment; Can we Learn More than they are Just Safe?
Robert W. W. Biederman, Carnegie Mellon University, Allegheny Health Network, Pittsburgh, PA, USA

Plaque Angiogenesis in Human Atherosclerosis
Erik A.L. Biessen, Maastricht University Medical Center, Maastricht, The Netherlands

Direct Effects of Dapagliflozin on the Diabetic Heart- Attenuation of Inflammation, Apoptosis and  Fibrosis
Yochai Birnbaum, Baylor College of Medicine, Houston, TX, USA  

The Impact of NSAIDs on CAD: Is there a Difference between Non-selective and Cox-2-selective Agents and, if so, WHY?
Jeffrey S. Borer, State University of New York Downstate Medical Center, New York, NY, USA  

Pulmonary Hypertension – Have we gone from a death sentence to a “forgettable disease” for many in 30 years?
Robert C. Bourge, The University of Alabama, Birmingham, Birmingham, AL, USA

Is it time to rethink our Model of Atrial Fibrillation and Stroke?
Jared Bunch, Intermountain Medical Center, Intermountain Heart Institute, Murray, Utah, USA

Novel Mechanisms of Vascular Dysfunction in Type 2 Diabetes
Hua Linda Cai, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

New Electrocardiographic Predictors of Sudden Cardiac Death
Michael E. Cain, University at Buffalo, Buffalo, NY, USA

Low Dose IGF1-role in Cardiac Cytoprotection and Repair from Mouse to Man
Noel Caplice, Biosciences Institute, University College Cork, Ireland

Echocardiographic Quantitation of Mitral Regurgitation
Hari P. Chaliki, Mayo Clinic, Scottsdale, AZ, USA

Pericardial cysts- revisited
Yzhar Charuzi, UCLA School of Medicine, Cedars Sinai Medical Center; Los Angeles, CA, USA

Inhibition of Glycosphingolipid synthesis as a novel approach to manage Metabolic Syndrome
Subroto Chatterjee, Johns Hopkins University School of Medicine, Baltimore, MD, USA

New Cardiovascular Risk Factors and Endothelial Dysfunction
Changyi (Johnny) Chen, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA 

Novel Mechanisms Underlying Smooth Muscle Phenotype and Vascular Remodeling
Shiyou Chen, University of Georgia, Athens, GA, USA

Molecular Regulation of Extracellular Matrix in Vascular Aging
Yabing Chen, University of Alabama at Birmingham, Birmingham, AL, USA

Upstream Mediators of Inflammation and the Potential to Unlock Paradoxes of Age-Related Disease
Susan Cheng, Brigham and Women's Hospital, Boston, MA, USA

Secondary Stress Cardiomyopathy- Unique Challenges in The Critically Ill
Anand Chockalingam, University of Missouri – Columbia, Columbia, MO, USA

Coronary Microvascular Dysfunction in Ischemic Heart Disease
Filippo Crea, Catholic University, Roma, Italy

Improvement in Quality of Care for Atrial Fibrillation in Get with The Guidelines – Atrial Fibrillation (GWTG-AFIB)
Anne B. Curtis, University at Buffalo, Buffalo, NY, USA

mTOR signaling in Diabetes and Myocardial Infarction
Anindita Das, Virginia Commonwealth University, Richmond, VA, USA

Stratification of Arrhythmic Risk in Adult Patients with Congenital Heart Disease (CHD)
Luciano Daliento, University of Padua, Italy

Temporary Mechanical Support for the Right Ventricle: Pre-Implant Patient Selection, Device Recipient Surveillance and Weaning of Patients from the Support System
Michael Dandel, Deutsches Herzzentrum, Berlin, Germany

Surgical Management of Aortic Root Abscess
Piroze Davierwala, Herzzentrum Leipzig, Leipzig, Germany

Where are we with Bone Marrow Cell Therapy for Heart Repair?
Buddhadeb Dawn, University of Kansas Medical Center, KS, USA

Asymptomatic Esophageal Complications Related To Atrial Fibrillation Ablation – Relation to Esophageal Perforating Complications
Thomas Deneke, Cardiovascular Center Bad Neustadt, Germany

CO2 Water-bath as a Novel Therapy for the Treatment of Peripheral Artery Disease in Diabetes
Naranjan S. Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Canada 

Statin Modifies the Association of Fish Consumption with Incidence of Heart Failure: The Physicians’ Health Study
Luc Djousse, Brigham and Women's Hospital, Boston, MA, USA

Cellular Electrophysiological Mechanisms of Paroxysmal Atrial Fibrillation in Patients
Dobromir Dobrev, University Duisburg-Essen, Essen, Germany

Sodium Restriction in Chronic Heart Failure: take it with a pinch of salt?
Rami Doukky, Cook County Health and Hospitals System, Chicago, IL, USA

The Role of the Heart Failure Clinic in 2017: Time for a Shift Toward Virtual Follow-Up?
Anique Ducharme, Institut de cardiologie de Montréal, Montréal, QC, Canada

Diabetes, Inflammation, and Arrhythmic Risk
Samuel C. Dudley, Brown University, The Miriam and Rhode Island Hospitals, Providence, RI, USA 

Estimation of Immediate Pre-dissection Aortic Diameter – Important and Surprising Information
John A. Elefteriades, Yale University School of Medicine, New Haven, CT, USA

Evaluation of Coronary Artery Disease in Obese Patients. The Role of Non-Invasive Cardiac Imaging
Abdou Elhendy, Marshfield Clinic, Marshfield, WI, USA

Sex Differences in Biomarkers of Heart Failure
DeLisa Fairweather, Mayo Clinic, Jacksonville, FL, USA

Acute Coronary Syndromes: A Role for Inflammation and its Resolution 
Janos G. Filep, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

Lack of Awareness of and Adherence to Optimal Heart Rate Control in Heart Failure with Reduced Ejection Fraction: Insight from Survey of Heart Rate in Heart Failure in Sweden (HR-HF Study)
Michael Fu, Sahlgrenska University Hospital/Östra Hospital, Göteborg, Sweden

The Vasculome: Splitting, Lumping, and the Rubik’s Cube Dilemma
Zorina S. Galis, NHLBI, Bethesda, MD

Novel Mechanism of Exercise-Induced Cardiovascular Protection: Role of Exosomes
Feng Gao, The Fourth Military Medical University, Xi'an, China

Determination of Optimal Viewing Angles for X-ray Coronary Angiography Based on a Quantitative Analysis of 3D Reconstructed Models
Joel A. Garcia, Orlando Health -Mid-Florida Cardiology, Orlando, FL, USA

How to improve assessment of cardiac tissue remodeling
A. Martin Gerdes, New York Institute of Technology, Northern Blvd, Old Westbury, NY, USA 

Thromboembolic Complications of Abdominal Aortic Aneurysm:  Mechanisms of Pathogenesis and Lessons from Prinzmetal’s Angina
S. David Gertz, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

Advances in the risk stratification of bicuspid aortic valve associated aortopathy
Evaldas Girdauskas, University Heart Center Hamburg, Germany

The Search for Vulnerable Plaque: Holy Grail or Fool’s Errand
James A. Goldstein, Beaumont Health System, Royal Oak, MI, USA

Activation of Adiponectin Receptor Induces Proprotein Convertase Subtilisin/Kexin Type 9 Expression but Ameliorates Lipid Profiles in Mice
Jihong Han, Nankai University, Tianjin, China

Imaging of the RV – Lessons Learned from Pulmonary Arterial Hypertension
Yuchi Han, University of Pennsylvania, PA, USA

Center Expertise and Outcomes in Thoracic Transplantation?
Don Hayes, Jr., Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA

Cost-Effectiveness of new Interventions for Heart Failure
Paul A. Heidenreich, Palo Alto VA Health Care System, Stanford University, Palo Alto, CA, USA 

The Multilayer Flow Modulator Stent for the Treatment of Aortic Aneurysms and Type B Dissections
Michel Henry, Bofferdange, Luxembourg

Adventures in Onco-Cardiology; the Role of Strain Imaging
Brian D. Hoit, Case Western Reserve University, Cleveland, OH, USA

Cardiac Ryanodine Receptor Channelopathies
Minoru Horie, Shiga University of Medical Sciences, Seta-Tsukinowa, Ohtsu, Japan

Diagnosis and Management of Arrhythmia in Suspected Channelopathies
Dan Hu (Helen), Masonic Medical Research Laboratory, Utica, NY, USA 

Coronary Artery Perforation - the Bane of an Interventional Cardiologist
Deepak Jain, II Medical Clinic, Sana Kliniken Luebeck, Lübeck, Germany

Beta3-adrenoceptors, Catecholamines and Stress
Daniela Jezova, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia

Do New Studies/Devices Tip the Balance to Earlier LVAD Implantation?
Maryl R. Johnson, University of Wisconsin-Madison, Madison, WI, USA

Aging and Obesity
Bodh I. Jugdutt, University of Alberta and Hospitals, Edmonton, AB Canada 

Pregnancy and Heart Failure Risk in Women with Congenital Heart Disease
Andreas Kalogeropoulos, Emory University School of Medicine, Atlanta, GA, USA

Blood Urea Nitrogen Reflects the Complexity of Cardiorenal Interactions in Heart Failure
Amir Kazory, University of Florida, Gainesville, FL, USA

Evidence Based Use of Handheld Ultrasound in Clinical Cardiology
Ilan Kedan, Cedars-Sinai Heart Institute, Beverly Hills, CA, USA

Targeted Therapeutic Strategy in High-Risk Plaque
Jin Won Kim, Guro Hospital, Korea University Medical School, Seoul, Republic of Korea

The Second Arterial Graft for CABG – Radial Artery or RIMA (Right Internal Mammary Artery)?
Philippe Kolh, University Hospital (CHU, ULg) of Liege, Liege, Belgium

Clinical Significance of Exaggerated Exercise Blood Pressure
Peter Kokkinos, Veterans Affairs Medical Center, Washington, DC, Georgetown University School of Medicine, George Washington University School, University of South Carolina, USA

Mitochondrial Homeostasis, VSMC Plasticity and Vascular Calcification
Wei Kong, Peking University Health Science Center, Beijing, China

Chitotriosidase as Non-Lipid Marker of Early Atherosclerosis and Prognostic Factor in Cardiovascular Events
Tatyana Korolenko, Institute of Physiology and Fundamental Medicine, Novosibirsk, West Siberia, Russia

Novel and Emerging Intravascular Imaging Modalities
Santhosh Koshy, University of Tennessee, Memphis, TN, USA

Cardioprotection in Diabetic Heart with PDE5 Inhibition and Hydroxychloroquine
Rakesh C. Kukreja, Pauley Heart Center, Richmond, VA, USA

Role of ECMO in Advanced Critical Cardiac Care Management
Adarsh Kumar, Govt. Medical College/G.N.D. Hospital, Amritsar, India

Endothelin-1 and Coronary Vasomotor Dysfunction: Role of p38 Kinase and NADPH Oxidase
Lih Kuo, Texas A&M University Health Science Center, Temple, TX, USA 

Risk Stratification in Asymptomatic Wolf-Parkinson-White pattern: The Ongoing Debate
Martin J. LaPage, University of Michigan, Ann Arbor, MI, USA

AHA'S Cardiovascular Health Metrics, COPD, AND CVD
Hwa Mu Lee, University of California at Irvine, Anaheim, CA, USA

Immunological Concepts Driving Atherosclerotic Plaque Regression
Stephanie Lehoux, Lady Davis Institute, McGill University, Montreal, QC, Canada

Mitophagy and Cardiac Homeostasis
Qiangrong Liang, New York Institute of Technology, Old Westbury, NY, USA

When Answers Cannot Be Found in The Textbook – Making Decisions in Children with Profound Disabilities
Avraham Lorber, Rappaport Faculty of Medicine – Technion, Haifa, Israel

The Ischemic Continuum: What Is the Significance of a Lower Fractional Flow Reserve
Amir S. Lotfi, Baystate Medical Center, Springfield, MA, USA 

The Serpin Solution; Serpins as Therapeutics
Alexandra Lucas, University of Florida, Gainesville, FL, USA 

Regulated Exocytosis in Endothelial Cells: Biology and Clinical Implications
Jincai Luo, Institute of Molecular Medicine, Peking University, Beijing, China

Alteration of Autophagy Flux and Their Role in Diabetic Cardiac Injury
Xin-Liang Ma, Thomas Jefferson University, Philadelphia, PA, USA

A Current Update on Influenza and Cardiovascular Diseases
Mohammad Madjid, University of Texas at Houston Health Science Center, Houston, TX, USA

The Complimentary Role of Anatomy and Physiology in Predicting Patient Outcome: Where Do Cardiac CT and Stress Myocardial Perfusion Imaging Fit?
John J. Mahmarian, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX, USA

Extending Longevity in the Cardiovascular System: New Beginnings for Novel Treatments
Kenneth Maiese, Rutgers University of Medicine & Dentistry of New Jersey, Newark, NJ, USA

The Role of Genetics in Targeting Lifestyle Changes and Preventing Heart Disease
Shaista Malik, Women’s Heart Center, University of California, Irvine, Orange, CA, USA

Angiographic Contrast-Induced Vascular and Renal Toxicity - A Nanomedical Approach
Tadeusz Malinski, Ohio University, OH, USA

Interventions for Stroke Prevention: What Should a Cardiologist Do?
James D. Marsh, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Are Low Doses of Direct-Acting Oral Anticoagulants Justified and Appropriate in Patients with Nonvalvular Atrial Fibrillation?
Antoni Martínez-Rubio, University Hosp. of Sabadell, University Autonoma of Barcelona, Sabadell, Spain

New Molecular Targets of VEGF Signaling in Cardiovascular Disease
Nilanjana Maulik, University of Connecticut School of Medicine, Farmington, CT. USA

Inflammation and Autophagy in Myocardial Ischemia
Jawahar L. Mehta, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Sutureless Valves Can Cover the Gap Between Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement: The Minimally Invasive Solution
Antonio Miceli, Istituto Clinico Sant'Ambrogio, Gruppo Ospedaliero San Donato, Milan, Italy

Bioelectric Stimulation: The New Science to Enhance Tissue and Organ Repair
Leslie W. Miller, Leonhardt Ventures, Tampa, FL, USA

Aspirin for Primary Prevention of CVD: Advances in Diagnosis and Treatment
Samia Mora, Brigham and Women's Hospital, Boston, USA

Improving Cardiac Function in Pulmonary Arterial Hypertension: Is There a Role for Exercise Training?
Daniel Moreira-Goncalves, University of Porto, Porto, Portugal

Update On Chest Compression Only CPR for Withness Cardiac Arrest Victims
Mohammad-Reza Movahed, The Southern Arizona VA Health Care System, Tucson, AZ, USA

VADS in the Elderly: A Viable Option
Nandini Nair, Texas Tech Health Sciences Center, Lubbock, TX, USA

Targeting Cathepsin K in Cardiovascular Disease
Sreejayan Nair, University of Wyoming, Wyoming, USA

5-Years Outcome of Surgical Treatment of Severe Mitral Regurgitation with or Without Leaflet Prolapse
Francesco Nappi, Centre Cardiologique du Nord de Saint-Denis, France

High Risk Patient with CAC=0: Statin or Not
Khurram Nasir, Baptist Health South Florida, Coral Gables, FL, USA

Genes Involved in the Inflammation of the Artery Wall
Mohamad Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 

Role of the Adipokine Omentin in Cardiovascular Disease
Noriyuki Ouchi, Nagoya University Graduate School of Medicine, Nagoya, Japan

Role of Apelin/Apelin Receptor Axis in Heart Disease: Therapeutic role of Apelin Analogs
Gavin Y. Oudit, University of Alberta, Edmonton, AB, Canada

Mechanisms of myocardial ischemia/reperfusion injury and protection
Pasquale Pagliaro, Università di Torino, Ospedale S. Luigi, Orbassano (TO), Italy

Histone Deacetylase Inhibitors Prevent Cardiac Hypertrophic Remodeling and Dysfunction in Npr1 Haplotype Mice
Kailash N. Pandey, Tulane University School of Medicine, New Orleans, LA, USA

Utilization of 3-D Mapping in RF Ablation of Typical Atrial Flutter
Hakan Paydak, UAMS, Division of Cardiovascular Medicine, Little Rock, AR, USA

OMVC001 (DuraGraft) Vascular Graft Treatment in Patients Undergoing CABG
Louis P. Perrault, Montreal Heart Institute, Montreal, Quebec, Canada

Trends of Cardiovascular Risk Factors (Framingham Risk Score) in Patients with Acute Myocardial Infarction
Ygal Plakht, Ben Gurion University of the Negev, Beer-Sheva, Israel

Big data in Cardiology - Where we should be going and why?
Rahul Potluri, Aston University, Birmingham, UK

Immune Cell Alterations in Heart Failure
Sumanth D. Prabhu, University of Alabama at Birmingham, Birmingham, AL, USA

Low Serum Levels of Soluble Receptor for Advanced Glycation End Products is not a Universal Risk Biomarker for Cardiovascular Disease
Kailash Prasad, University of Saskatchewan, Saskatoon, SK, Canada

Clinical Importance of Cardiac Calcifications
Gregg S. Pressman, Einstein Medical Center, Philadelphia, PA, USA

Dilated Aorta: Is It Safe to Perform Exercise Echocardiography?
Maria Prokudina, Federal Medical Research Centre, Almazov North-West Medical Research Center, St. Petersburg, Russia

Lifestyle Factors and the Impact On Lifetime Incidence and Mortality of Coronary Heart Disease
Paolo Emilio Puddu, Sapienza University of Rome, Roma, Italy

Why it is Time to Abandon the Almost 100 Year Old Ways to Adjust the QT Interval for Heart Rate and Adopt a New Modern Approach
Simon W. Rabkin, University of British Columbia, Staff, Vancouver Hospital, Vancouver, BC, Canada

Non-Platelet Thromboxane Generation as a Novel Predictor of Mortality
Jeffrey J. Rade, UMASS Medical School, Worcester, MA, USA

Valve Prosthesis - Patient Mismatch: Keep It Simple
Shahbudin H. Rahimtoola, University of Southern California, Los Angeles, CA, USA

Gut Microbiota: An Innovative Target for Treatment of Hypertension
Mohan K. Raizada, University of Florida, Gainesville, FL, USA

Osteocardiology: Mechanisms of Bone Formation in the Heart
Nalini M. Rajamannan, Mayo Clinic, Rochester, MN, USA

Nutraceuticals in the Prevention and Treatment of Atherosclerosis
Dipak P. Ramji, Cardiff University, Cardiff, UK

Diastolic Heart Failure and Atrial Fibrillation the Twin Evil Epidemic in The Elderly
Hanumanth K. Reddy, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex?
Judith G. Regensteiner, University of Colorado School of Medicine, Aurora, CO, USA

Radiation Hazards in the Cath Lab?
Ariel Roguin, Rambam Medical Center, B. Rappaport - Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel

Optimizing Statin Utilization and Treatment Adherence Among Patients Who Discontinue Statins Due to Adverse Muscle Events
Robert S. Rosenson, Mount Sinai Icahn School of Medicine, Mount Sinai Hospital, New York, NY, USA

Improving Quality of Life in Patients with Chronic Heart Failure: Overcoming Exercise Intolerance
Hani N. Sabbah, Henry Ford Heart & Vascular Institute, Detroit, MI, USA

Comparison of Computed Tomography derived Fractional Flow Reserve to invasive Fractional Flow Reserve in Diagnosis of Functional Coronary Stenosis
Rajesh Sachdeva, Morehouse School of Medicine, Atlanta, Georgia, USA

The Critical Role of Mitochondria in the Pathogenesis and Treatment of Heart Failure
Saul Schaefer, University of California Davis, VA Northern California Health Care System, CA, USA

The Spasmogenic Action of the Proteasome Inhibitor Carfilzomib on Arterial and Venous Conduits from Patients Undergoing Coronary Artery Bypass Graft Surgery is Accentuated by Preexisting Type II Diabetes
Tiziano M. Scarabelli, The University of Alabama at Birmingham, Birmingham, AL, USA

Molecular Imaging of Myocardial Cannabinoid Type 1 Receptor and Angiotensin II Type 1 Receptor with PET Imaging
Thomas H. Schindler, Johns Hopkins University, Baltimore, MD, USA

Treatment of Arrhythmias in The Elderly: Specific Age Related Considerations
Karlheinz Seidl, Klinikum Ingolstadt GmbH, Ingolstadt, Germany

Emerging Role of Cellular Therapy (Stem Cell Therapy) in Coronary Artery Disease
Rakesh K. Sharma, University of Arkansas Medical Science, El Dorado, AR, USA

Ventricular Arrhythmias in Cardiac Sarcoidosis: Recognition and Management
Jayaprakash Shenthar, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India 

Acidified Atherosclerotic Lesions Allow Non-Radioactive Lesion Imaging in Live Mice
Guo-Ping Shi, Brigham and Women’s Hospital, Boston, MA, USA

Cardiovascular Risks of Recreational Marijuana Use
Jamshid Shirani, St. Luke's Hospital and Health Network, Bethlehem, PA, USA

IL-10 and Toll like receptors 2 and 4 in Cardiac Stress Conditions
Pawan K. Singal, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB, Canada 

Inflammation in Cardiac Diseases
Dinender K. Singla, College of Medicine, University of Central Florida, Orlando, FL, USA

Attenuation of Angiotensin II- induced Signaling Events and Egr-1 expression by cyclic AMP in VSMC
Ashok K. Srivastava, University of Montreal, Montreal, QC, Canada 

Pulmonary Vein Potentials and Dormant Conduction
Komandoor Srivathsan, Mayo Clinic, Phoenix, AZ, USA

Transvenous Lead Extraction with Percutaneous Aspiration of Large Lead Vegetations Using an Extracorporeal Suction Device
Christoph T. Starck, German Heart Center Berlin, Berlin, Germany

Percutaneous Hemodynamic Support Devices in The Current Day Cath Lab
Madhan Shanmugasundaram, University of Arizona College of Medicine, Tucson, AZ, USA

The Prognostic Impact of Single Extra-Stimulus on Programmed Ventricular Stimulation in Brugada Patients without Previous Cardiac Arrest
Masahiko Takagi, Osaka City University Graduate School of Medicine, Osaka, Japan

Impact of Reactive Oxygen Species on Coronary Atherosclerosis
Mitsuyasu Terashima, Toyohashi Heart Center, Oyama-cho, Toyohashi, Japan

Left Main Coronary Artery Disease Treatment: PCI vs CABG
Luca Testa, IRCCS Policlinico S. Donato, San Donato M.ne, Milan, Italy

Management of Stable Angina –  European, Canadian, British and American Scientific Society Guidelines: A Critical Appraisal
Udho Thadani, University of Oklahoma Health Sciences Center and VA Medical Center
Oklahoma City, OK, USA 

Macropahges and Cardiac Repair  
Edward Thorp, Feinberg School of Medicine, Chicago, IL, USA

Can Presence of Aortic Plaque Predict Coronary Heart Disease?
Takanobu Tomaru, Toho University, Sakura Hospital, Japan

Atrial Remodeling in AF: Current Understanding and Therapeutic Implications
Teresa S.M. Tsang, UBC Department of Medicine, Vancouver, BC, Canada

Ketogenic Signaling and BDH1 as Early Biomarkers of DCM
Balwant Tuana, University of Ottawa, ON, Canada

How to Predict the Long-Term Outcome of New Stents?
Yasunori Ueda, NHO Osaka National Hospital, Osaka University Graduate School of Medicine
Osaka, Japan

Update on the Status of CTO PCI
Barry F. Uretsky, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Transcatheter Mitral Valve Replacement. State of The Art
Gian Paolo Ussia, Policlinico Tor Vergata, University of Rome, Tor Vergata, Italy

Measuring Resistance in the Coronary Microcirculation
Niels van Royen, VU University Medical Center, Amsterdam, The Netherlands

Therapy of Hypertrophic Obstructive Cardiomyopathy
Josef Veselka, University Hospital Motol, Prague, Czech Republic

Hemodynamic Support for High Risk PCI and Cardiogenic Shock: Finding the Sweet Spot
George W. Vetrovec, VCU Pauler Heart Center, Virginia Commonwealth University, VA, USA

Paradoxical Hookah Smoking-Induced Augmentation of Endothelial Function
Ronald G. Victor, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Repetitive Transient Ischemia-Induced Cardiac Angiogenesis is Mediated by CaMKIIi Activation
Yanggan Wang, Zhongnan Hospital of Wuhan University, Wuchang District, Wuhan, China

The Future of Diagnostic Coronary Angiogram
Giora Weisz, Columbia University Medical Center, NY, USA and the Hebrew University, Jerusalem, Israel

Geriatric Cardiology: Octogenarian Pearls
Nanette K. Wenger, Emory University School of Medicine, Atlanta, GA, USA 

A-kinase Interacting Protein 1 In Cardiac Hypertrophy and Heart Failure
B. Daan Westenbrink, University Medical Center Groningen, Groningen, The Netherlands

Cardiac MRI REST-stress mr perfusion Imaging-Decision Making of Heart Disease and Outcome
Norbert Wilke, University of Florida, Gainesville, FL, USA

Strategies for CVD Risk Reduction in Diabetes
Nathan D. Wong, University of California, Irvine, CA, USA

Timing of PCI in non-STEMI: Do Newer Data Suggest we change our Practice Paradigm?
Scott Wright, Mayo Clinic, Rochester, MN, USA

Focused Reading Sessions Improve Correlation of Echocardiographic Assessment of Right Ventricular Systolic Function with Right Ventricular Ejection Fraction by Cardiac Magnetic Resonance Imaging
Bo Xu, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

New Insights into Myocardial Ischemia/Reperfusion Injury --- How to DAMPen a RAGE-ing heart 
Zequan Yang,University of Virginia, Charlottesville, VA, USA

Ischemic Injury Defines the Reperfusion Injury --- No Reperfusion Injury is Without Ischemic Necrosis
Zequan Yang, University of Virginia, Charlottesville, VA, USA

TAVI for Pure Aortic Regurgitation
Jian (James) Ye, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada

Golden Ratio: A Subtle Regulator in Our Body and Cardiovascular System
Ertan Yetkin, International Medical Center, Mercin, Turkey

Comprehensive multimodal intra-vascular optical imaging without exogenous contrast agent
Hongki Yoo, Hanyang University, Seoul, Republic of Korea

A Novel Cell Penetrating Peptide, Cardiac Targeting Peptide Appears to Utilize Cardiac Channels for Transduction
Maliha Zahid, University of Pittsburgh, Pittsburgh, PA, USA 

Strategies to Overcome the Road Blocks in Cardiac Cell Therapy
Jianyi (Jay) Zhang, UAB, The University of Alabama at Birmingham, Birmingham, AL, USA

Increased Vulnerability of Failing Hearts to Sympathetic Stimulation Induced Atrial Fibrillation:
The Role of Ryanodine Receptor Dysfunction
Youhua Zhang, New York Institute of Technology (NYIT) College of Osteopathic Medicine
Old Westbury, NY, USA 

The Roles of Estrogen Metabolite 2-Methoxyestradiol in Vascular Health
Xi-Long Zheng, University of Calgary, Calgary, AB, Canada

 

 

 

Affiliated with


 

    international academy of cardiology

 IACS